Thrive IV (508 848-8089) in Massachusetts has announced a physician-approved ketamine IV therapy to relieve symptoms associated with chronic pain and depression conditions.
Dartmouth, United States - August 4, 2023 —
With this announcement, Thrive IV offers patients who suffer from these conditions, as well as fibromyalgia, chronic migraine headaches, phantom limb pain, or pain related to trauma, stroke, spinal injuries, MS, Lyme and depression an effective alternative to pain and SSRI medications.
Interested parties can learn more at https://www.thriveiv.net/
With up to 40% of American adults suffering from chronic pain-related symptoms, the clinic's ketamine IV therapy is intended to provide long-term relief for those patients who have not responded well to traditional treatments.
Ketamine is an anaesthetic shown in recent studies to be beneficial in diminishing chronic pain due to conditions like neuralgia, neuropathic pain from peripheral nerve damage, complex regional pain syndrome, cancer-related neuropathic pain, post-operative pain, and more. It has clearly been shown to elevate mood and rewire the brain to stop depression.
Ketamine is able to block the N-methyl-D-aspartate receptor (NMDAR) which plays an important role in the development and chronic pain and the persistent depressive and sad, hopeless thoughts. This substance interacts with patients' neural pathways to help undo signals that elicit a pain response as well as reverse and regrow the nerve connections that will elevate mood and stop depression. Ketamine has also been proven highly effective in alleviating depression, which is a condition that many chronic pain patients develop.
At Thrive IV, patients with chronic nerve pain conditions often receive a Two to 4-hour ketamine IV infusion to begin their treatment. During the therapy sessions, patients' vital signs will be monitored carefully by Thrive IV staff, who also adjust the IV treatment based on a patient's response.
Mood infusions for depression, PTSD and anxiety are usually 6 treatments each approximately 40minutes to an hour administered over the course of 2-4 weeks.
Thrive IV said it strives to issue the least amount of ketamine sessions necessary to alleviate a patient's pain and or overwhelming depressive thoughts and feelings. On average, patients receive a series of six infusions over a 2-4 week period. Pain infusions may be only needed as a single infusion or depending on the specific time of pain, it may be necessary to have several infusions over weeks.
Located in Dartmouth, Massachusetts, Thrive IV was founded by Dr. Michael Pellegrino who has been serving communities in the southeastern Massachusetts region since 1996. Dr. Pellegrino has clinical experience not only in Ketamine therapy but also in osteopathy, acupuncture, and is certified in emergency medicine.
Thrive IV also offers vitamin infusion therapies for ketamine patients and for a wide range of goals, including stronger immunity, exercise support, better hydration, and nutrition supplementation as well as to help increase the success of the ketamine therapy infusions.
"We specialize in adding Ketamine infusions to help increase your feeling of well-being and reduce the terrible pain, depression, or anxiety you've been experiencing," a spokesperson from the clinic said.
Interested parties can learn more and schedule a consultation with Thrive IV by visiting https://www.thriveiv.net/
Contact Info:
Name: Dr. Michael Pellegrino
Email: Send Email
Organization: Thrive IV
Address: 49 State Rd Nauset Building #102, Dartmouth, MA 02747, United States
Phone: +1-508-848-8089
Website: http://www.ThriveIV.net
Source: PressCable
Release ID: 89104133
Should you detect any errors, issues, or discrepancies with the content contained within this press release, or if you need assistance with a press release takedown, we kindly request that you inform us immediately by contacting error@releasecontact.com. Our expert team will be available to promptly respond and take necessary steps within the next 8 hours to resolve any identified issues or guide you through the removal process. We value the trust placed in us by our readers and remain dedicated to providing accurate and reliable information.
